At-home misoprostol increases rate of day-care procedures and patient satisfaction in late medical abortion
1. 71% of home group patients and 46% of hospital group patients completed abortion as a day-care procedure. 2. Majority...
Obstetrics
Reports of high-impact obstetrics and gynecology studies by medical professionals
COVID-19 vaccination and infection not associated with increased risk of congenital anomalies
1. In a cohort of infants born to mothers during the COVID-19 pandemic, neither vaccination nor infection with COVID-19 led...
Healthy prenatal dietary patterns may be protective against offspring autism
1. The data from two cohort studies show that the chances of receiving an autism diagnosis was decreased in mothers...
Poor cardiovascular health is a risk factor for female infertility
1. Cardiovascular health and infertility are negatively correlated with physical activity, BMI, and blood glucose being major indicators of cardiovascular...
Bariatric surgery may improve rates for spontaneous ovulation in patients with polycystic ovarian syndrome and obesity
1. Women in the surgical group reported 2.5 times more spontaneous ovulations than in medical therapy. 2. Those assigned to...
Nutrition source does not influence weight gain for moderate-to-late-preterm infants
1. In this randomized controlled trial, the body-fat percentage among preterm infants was similar between those who received parenteral nutrition...
Topiramate for prenatal antiseizure therapy is not associated autism spectrum disorder
1. In this retrospective cohort study, exposure to antiseizure medications was associated with a higher incidence of autism spectrum disorder...
Early intrauterine growth restriction may be associated with impaired neurodevelopment
1. Restricted growth of a fetus during early pregnancy was examined as a risk factor for impaired neurodevelopment. 2. Decreased...
Prenatal opioid exposure not associated with increased risk of neuropsychiatric disorders in children
1. In a cohort study in South Korea, prenatal opioid use did not significantly increase the risk of neuropsychiatric disorders...
Pembrolizumab enhances progression-free survival in patients with locally advanced cervical cancer
1. Progression-free survival at 24 months was higher in the pembrolizumab versus placebo-controlled group. 2. The pembrolizumab-chemoradiotherapy group reported slightly...
License Our Award-Winning Physician-Written Medical News and Visual Abstracts
2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.
